Global plan for insecticide resistance management in malaria vectors

More documents

Recommendations

Info

ContributorsThe Global Plan for Insecticide Resistance Management in malariavectors (GPIRM) was prepared in consultation with members ofeach of the constituencies of the Roll Back Malaria Partnership.The WHO Global Malaria Programme would like to thank the manyindividuals and institutions that participated in preparation ofthe GPIRM for their invaluable advice provided in interviews andconsultations, comments on the initial fact base or review of thefinal document.Tarekegn Abeku, Malaria Consortium, London, United Kingdomof Great Britain and Northern IrelandRabindra Abeyasinghe, WHO Country Office for Papua NewGuinea, Port Moresby, Papua New GuineaNicole Achee, Uniformed Services University of the HealthSciences, Bethesda, Maryland, USADoreen Ali, National Malaria Control Programme, Lilongwe,MalawiPedro Alonso, Barcelona Centre for International Health Research,Barcelona, SpainChioma Amajoh, National Malaria Control Programme, Abuja,NigeriaBirkinesh Ameneshewa, WHO Regional Office for the AfricanRegion, Inter-country Support Team East and Southern Africa,Harare, ZimbabweHoda Atta, WHO Regional Office for the Eastern MediterraneanRegion, Cairo, EgyptRifat Atun, Global Fund to Fight AIDS, Tuberculosis and Malaria,Geneva, SwitzerlandKate Aultman, Bill & Melinda Gates Foundation, Seattle,Washington, USASam Awolola, Institute for Medical Research, Lagos, NigeriaMagaran Bagayoko, WHO Office for the African Region,Brazzaville, CongoSuprotik Basu, Office of the United Nations Secretary-General’sSpecial Envoy for Malaria, New York City, New York, USAGregory Beavers, Armed Forces Pest Management Board,Washington, District of Columbia, USAAllison Belemvire, United States President’s Malaria Initiative,United States Agency for International Development, Washington,District of Columbia, USADavid Brandling-Bennett, Bill & Melinda Gates Foundation,Seattle, Washington, USAWilliam Brogdon, United States President’s Malaria Initiative,United States Centers for Disease Control and Prevention, Atlanta,Georgia, USAValentina Buj, United Nations Children’s Fund (UNICEF), New YorkCity, New York, USANichola Cadge, United Kingdom Department for InternationalDevelopment, London, United Kingdom of Great Britain andNorthern IrelandKate Campana, Malaria No More, New York City, New York, USAKent Campbell, Malaria Control and Evaluation Partnership inAfrica (MACEPA), Seattle, Washington, USAPierre Carnevale, Institut de recherche pour le développement,Montpellier, FranceKeith Carter, WHO Regional Office for the Americas, Washington,District of Columbia, USAEmanuel Chanda, National Malaria Control Programme, Lusaka,ZambiaFabrice Chandre, Institut de recherche pour le développement,Montpellier, FranceChang Moh Seng, WHO Regional Office for the Western Pacific,Manila, PhilippinesDesmond Chavasse, Population Services International (PSI),Nairobi, KenyaJohn Chimumbwa, RTI International, Nairobi, KenyaJohn Chipwanya, National Malaria Control Programme, Lilongwe,MalawiEva Christophel, WHO Regional Office for the Western Pacific,Manila, PhilippinesThomas Churcher, Infectious Disease Epidemiology, ImperialCollege London, London, United Kingdom of Great Britain andNorthern Ireland
Richard Cibulskis, Global Malaria Programme, WHO, Geneva,SwitzerlandAlison Clements-Hunt, WHO Consultant, Geneva, SwitzerlandMaureen Coetzee, Malaria Entomology Research Unit, WitsUniversity, Johannesburg, South AfricaJustin Cohen, Clinton Health Access Initiative, Boston,Massachusetts, USAJide Coker, National Malaria Control Programme, Abuja, NigeriaMike Coleman, Liverpool School of Tropical Medicine, Liverpool,United Kingdom of Great Britain and Northern IrelandFrank Collins, University of Notre Dame, South Bend, Indiana, USAMarc Coosemans, Institute of Tropical Medicine, University ofAntwerp, Antwerp, BelgiumVincent Corbel, Institut de recherche pour le développement,Cotonou, BeninAllen Craig, United States President’s Malaria Initiative, UnitedStates Centers for Disease Control and Prevention, Lusaka,ZambiaJanice Culpeper, Bill & Melinda Gates Foundation, Seattle,Washington, USAAditya Prasad Dash, WHO Regional Office for South-East Asia,New Delhi, IndiaPeter DeChant, Valent BioSciences, Libertyville, Illinois, USAAkshay Dhariwal, National Vector Borne Disease ControlProgramme, New Delhi, IndiaAbdoulaye Diop, Programme National de Lutte contre lePaludisme, Dakar, SenegalThomas Eisele, Tulane University, New Orleans, Louisiana, USAMikhail Ejov, WHO Regional Office for Europe, Copenhagen,DenmarkSalaheldin Elkhalifa, WHO Regional Office for the EasternMediterranean Region, Cairo, EgyptKhalid El Mardi, National Malaria Control Programme, Khartoum,SudanRainier Escalada, WHO Regional Office for the Americas,Washington, District of Columbia, USAScott Filler, Global Fund to Fight AIDS, Tuberculosis and Malaria,Geneva, SwitzerlandChristen Fornadel, United States President’s Malaria Initiative,United States Agency for International Development, Washington,District of Columbia, USAAzra Ghani, Infectious Disease Epidemiology, Imperial CollegeLondon, London, United Kingdom of Great Britain and NorthernIrelandJohn Gimnig, United States President’s Malaria Initiative, UnitedStates Centers for Disease Control and Prevention, Atlanta,Georgia, USADavid Gittelman, United States President’s Malaria Initiative,United States Centers for Disease Control and Prevention, Atlanta,Georgia, USAJohn Govere, WHO Regional Office for the African Region,Inter-country Support Team East and Southern Africa, Harare,ZimbabweJoanne Greenfield, Australian Agency for InternationalDevelopment, Canberra, AustraliaStephanie Guillaneux, Global Malaria Programme, WHO, Geneva,SwitzerlandPierre Guillet, Vector Health International, Arusha, TanzaniaAhmad Ali Hanafi, School of Public Health, Teheran, IslamicRepublic of IranJanet Hemingway, Liverpool School of Tropical Medicine,Liverpool, United Kingdom of Great Britain and Northern IrelandJeffrey Hii, WHO Regional Office for the Western Pacific, Manila,PhilippinesAtsuko Hirooka, Sumitomo Chemical, Tokyo, JapanMark Hoppe, Syngenta, Stein, SwitzerlandStefan Hoyer, Global Malaria Programme, WHO, Geneva,SwitzerlandJohn Invest, Sumitomo Chemical UK, London, United Kingdom ofGreat Britain and Northern IrelandFumiharu Ishige, Sumitomo Chemical, Tokyo, Japan
Page 1 and 2: WHO Global Malaria ProgrammeGLOBAL
Page 4 and 5: Navigating the GPIRMExecutive summa
Page 8 and 9: Elissa Jensen, United States Presid
Page 11: ForewordThe past decade has seen un
Page 15 and 16: 1.3 Potential effectof resistance o
Page 17 and 18: 2.2 Country activitiesPillar I. Pla
Page 19 and 20: PART 3 TECHNICALRECOMMENDATIONSFOR
Page 23 and 24: PART 1THE THREAT OFINSECTICIDE RESI
Page 25 and 26: Attributes of the four classes of i
Page 27 and 28: 1.2 Status ofinsecticideresistance1
Page 29 and 30: 1.2.2 Resistance is widespread and
Page 31 and 32: Figure 7: Insecticide-resistance me
Page 33 and 34: The operational impact of resistanc
Page 35 and 36: Case study 2. Experimental hut tria
Page 37 and 38: Figure 12: Genetic heritability dri
Page 39 and 40: Figure 14: kdr West and kdr East mu
Page 41 and 42: Monitoring of insecticide resistanc
Page 43 and 44: Figure 15: Impact of insecticide re
Page 45 and 46: Figure 16: Potential applications o
Page 49 and 50: PART 2COLLECTIVE STRATEGYAGAINST IN
Page 51 and 52: Overview of the strategy against in
Page 53 and 54: 2.2.1 Pillar I. Plan and implement
Page 55 and 56: Step 2: Design an IRM strategy.Prin
Page 57 and 58:
Figure 20: Recommendations for moni
Page 59 and 60:
Examples of regional entomological
Page 61 and 62:
Establish a strong intersectoral bo
Page 63 and 64:
Standardized data format and timely
Page 65 and 66:
New products to supplement IRM stra
Page 67 and 68:
Currently, WHOPES addresses only pr
Page 69 and 70:
The practical issues in implementat
Page 71 and 72:
Adequate, sustainable human and fin
Page 73 and 74:
The overall cost increase is due to
Page 75 and 76:
2.5.3 Financial cost of monitoring
Page 77:
Obvious parallels can be drawn betw
Page 80 and 81:
Part 3Technical recommendations for
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 89 and 90:
PART 4NEAR-TERMACTION PLAN4.1 Role
Page 91 and 92:
• Convene experts to review new s
Page 93 and 94:
Figure 32: What should we do over t
Page 95 and 96:
Technical support to countries• P
Page 97 and 98:
Global database• Malaria-endemic
Page 99 and 100:
Within 1-2 years.Accelerated fundin
Page 101 and 102:
24. Ranson H et al. Pyrethroid resi
Page 103 and 104:
First steps in malaria vector contr
Page 105 and 106:
Vector control remains the single l
Page 107 and 108:
Annex 2 Long-lastinginsecticidal ne
Page 109 and 110:
Annex 3 History of insecticideresis
Page 111 and 112:
in many countries, will improve und
Page 113 and 114:
Annex 5 Example of ‘tippingpoint
Page 115 and 116:
Role of other factors.Recent studie
Page 117 and 118:
Annex 8 Main hypotheses usedto mode
Page 119 and 120:
Figure A8.2: Estimated impact of in
Page 121 and 122:
Combinations.How do combinations wo
Page 123 and 124:
Figure A9.2: Incremental annual cos
Page 125 and 126:
Annex 10 Genetic researchagendaBack
Page 127 and 128:
Table A11.1: Cost of indoor residua
Page 129 and 130:
References.1. United States Preside
Page 132:
For more information, please contac
show all

Global plan for insecticide resistance management in malaria vectors

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?